Asthma in toddlers and young children. Airway remodeling should be primary focus.
Opperwall
Barbara
B
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000402:Airway Obstruction / Q000209:etiology* / Q000517:prevention & control; D000403:Airway Resistance / Q000187:drug effects; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016535:Bronchial Hyperreactivity / Q000209:etiology / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D016903:Drug Monitoring / Q000379:methods; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D009722:Nurse Practitioners; D009730:Nursing Assessment / Q000379:methods; D010353:Patient Education as Topic / Q000379:methods; D011320:Primary Health Care / Q000379:methods*; D012307:Risk Factors; D013256:Steroids
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D020024:Leukotriene Antagonists; D013256:Steroids